AstraZeneca announces new anti-obesity drug deal and positive profit
AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug. In an investor update, the multinational pharmaceutical group also posted total revenue of $33.8bn for the…#astrazeneca #anglo #q3 #coreeps #pascalsoriot
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: AstraZeneca | China Health | Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Obesity